Pfizer’s long rap sheet of crime and fraud

In 2021 the New Zealand government enacted laws requiring citizens to take a novel vaccine based on mRNA technology.

Large sections of the population were not permitted to keep their jobs, or were segregated from normal civil life, unless they took this vaccine.

This vaccine was manufactured by Pfizer, a company with a long history of crime, fraud and corruption – a record which can only be described as disgraceful.

In late 2021 two widely-read articles about this history were published on Substack by KanekoaTheGreat and Jestre.

In the opening paragraph of his article, Jestre writes:

‘Imagine, if you will, an industry that is hated even more than government. Within that industry, there is a corporation that has a reputation so low that even among their peers, they were ranked as the worst in 2016, 2017, and 2018. Now imagine you are told if you do not let that company inject an experimental drug into you, using a never before tried delivery system, you will lose your livelihood, freedom, and possibly your life. You are not in the twilight zone. It is 2021 and that corporation is Pfizer.’

The following record combines Pfizer’s criminal history as outlined in each article.

Both authors insist their lists are by no means complete.

Advil

Pfizer’s Ibuprofen product Advil has been the subject of many lawsuits in the USA. The majority of these involve cases alleging severe adverse reactions. One such case related to a man who developed severe blistering over 35% of his body. Jestre believes a confidential out of court settlement was reached.

Aricept

This case invovling the Alzheimer’s drug Aricept though ultimately unsuccessful, ‘raised serious questions as to whether the FDA was colluding with the drug industry rather than protecting public health’, according to Jestre.

Bextra, Geodon, Zyvox and Lyrica

Pfizer was fined US$1.195 billion for promoting the off-label use of Bextra. Pfizer was ordered to pay a further US$1 billion in civil damages and penalties. US$102 million was given to six whistleblowers who had been fired by the company.

The company was charged with ‘misbranding’ the drug with intent to mislead.

Blackmail in Africa

Wikileaks blew the lid on Pfizer’s blackmailing practices in relation to a US$75 million payout in Nigeria as part of the ‘Trovan’ case.

Blue Cross Blue Shield

In this case it was revealed the Pfizer regularly organised large-scale luxury conferences for doctors, where they would give them gifts and a US$2,000 ‘stipend’ each. The litigation itself was a claim by Blue Cross Blue Shield to recover overpayments made to Pfizer for its Bextra drug.

Bribes in Europe

In 2020, Pfizer paid US$60.2 million dollars for violating the Foreign Corrupt Practices Act. Bribes were paid to government officials in Russia, Bulgaria, Croatia, Kazakhstan, Serbia, Czech Republic, China and Italy.

Celebrex, Bextra and Lyrica

Pfizer paid US$450 million to Brigham Young University (2012) after the university alleged that the company cheated them out of $9.7 billion in royalties for the creation of the drug.

Pfizer also paid out US$486 million (2016) to its own shareholders for hiding safety risks associated with Celebrex, Bextra and Lyrica.

Chantix

In 2013, Pfizer paid US$273 million to settle claims relating to Chantix, its ‘quit smoking’ drug, mainly for undisclosed serious side effects.

Delaware River Pollution

In 1991, Pfizer was fined US$3.1 million for illegally dumping untreated and treated industrial waste into the Delaware River.

Depo-Testosterone

Thousands of lawsuits have been filed over depo-testosterone, most of which are still ongoing without settlement, although those that have resolved have generally been in Pfizer’s favour.

Effexor

Multiple lawsuits alleging undisclosed serious adverse reactions over the anti-depressent Effexor were dismissed.

Eliquis

The Pfizer made blood-thinner Eliquis is currently the subject of multiple ongoing lawsuits alleging serious undisclosed adverse reactions.

Estring

Pfizer was accused of ‘fraudulent co-pay marketing’ in which they misled consumers over the final price they would have to pay for drugs. In the settlement Pfizer paid US$200,000 to each affected consumer.

Geodon

In 2009, Pfizer paid US$33 million for unfair and deceptive marketing practices for its anti-psychotic drug Geodon.

Heart Valves

Pfizer agreed to create a fund of between US$80-130 million for defective heart valves from use of its drugs, in particular those arising from the fracturing of its Bjork-Shiley Convexo-Concave heart valve product.

A separate court action claimed Pfizer lied to the US government in order to get approval for its heart valve product, which continues to fracture and has killed hundreds of patients worldwide.

Inlyta, Sutent and Tikosyn

In yet another case of deceptive marketing, Pfizer paid out US$23.85 million to settle a co-pay scheme and was required to undertake a 5 year period of ‘probation’ in relation to its marketing activities.

Lipitor

Thousands of cases alleging the Pfizer cholestrol medication Lipitor caused Type 2 diabetes were dismissed by a judge, although many legal experts have questioned the court judgment.

Lyrica and Zyvox

Pfizer reached a US$43 million settlement with authorities for illegally using incentives to promote these drugs to doctors. More litigation is expected for Lyrica for claims it has caused numerous birth defects.

Neurontin

In 2010 a jury found Pfizer guilty of ‘racketeering’ and was ordered to pay US$142 million to the claimants over its epilepsy drug Neurontin. Pfizer bribed doctors with luxury trips and planted its operatives in audiences at drug conferences.

Premarin

The Pfizer drug Prempro litigation follows thousands of cases filed by women who claimed the drug caused breast cancer. Pfizer paid US$330 million to settle more than 2,200 of these lawsuits, with many more thousands ongoing. Court records show there was, on the part of Pfizer, a “concerted effort to misdirect physicians” from the dangers of the drugs.

Pristiq

A case in which Pfizer settled with its own shareholders over claims it had misled them over the safety of the drug, to the tune of US$67.5 million.

Protonix

Pfizer paid US$55 million in fines for illegally promoting Protonix for off-label use, and a further fine of US$784.6 for underpaying drug rebates to Medicaid.

Rapamune

Pfizer was ordered to pay US$35 million to settle claims relating to the unauthorised use of transplant drug Rapamune. Allegations made in the claim said Pfizer bribed doctors to prescribe the drug, and provided ‘misleading presentations of data.’

Rezulin

Pfizer paid out US$750 million to settle 35,000 claims relating to its diabetes drug Rezulin.

Trovan

A case involving Nigerian children. According to Jestre:

‘Pfizer performed a clinical trial on 200 children without telling the parents that the treatment was experimental or obtaining informed consent. These children were paired off in groups of 100, with one group receiving Trovan, and the other group receiving the “gold standard” treatment at a reduced dosage in order to make their drug look better. Many of the children died or were permanently disabled. This led to a $75 million settlement, which Pfizer tried to stop by blackmailing government officials, as noted earlier.’

Viagra

Multiple lawsuits are in progress claiming Viagra to be responsible for a number of undisclosed health conditions, including cancer. All these actions were recently consolidated into a class action lawsuit.

Xalkori

New York University sued Pfizer alleging that the company failed to pay royalties on the drug.

Xeljanz

Xeljanz litigation is growing by the week as claimants allege Pfizer’s arthritis drug caused an array of serious adverse reactions, the risks of which were not disclosed by the company.

Zithromax

Pfizer reached a confidential settlement with various US state governments for deliberately failing to disclose some risks associated with use of this drug.

READ MORE: Mum’s testimony of vax injured 12 year old daughter Maddie De Garay